Recruiting
Study to Assess Linsitinib in Participants With Moderate to Severe Active Thyroid Eye Disease (TED)
NCT07753603
- Conditions
- Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +16 more
- Locations
-
- Advancing Research International Las Vegas, Nevada, United States